Meldonium use widespread among elite athletes
Research finds 43 of the 66 athletes who tested positive for meldonium during 2015 European Games in Azerbaijan did not declare it.
Source: Jimmie48 Photography / Shutterstock.com
On 7 March 2016, tennis player Maria Sharapova announced that she had tested positive for meldonium, a substance prohibited by the World Anti-Doping Agency (WADA) in January 2016.
Research used by WADA to ban the substance has now been published in the British Journal of Sports Medicine (online, 8 March 2016).
The authors studied drug declarations from athletes during the 2015 European Games in Baku, Azerbaijan, results from blood and urine doping tests.
Meldonium use was detected across 15 of the 21 sports at the Games and 13 medallists declared they were taking it. However, 43 of the 66 athletes who tested positive for meldonium did not declare taking the drug, which is thought to improve blood flow and aid recovery.
The researchers say the findings highlight the “excessive and inappropriate use” of the prescription drug among healthy athletes.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200868
Recommended from Pharmaceutical Press
Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.£22.00
Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.£38.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.£38.00
The Handbook of Pharmaceutical Excipients contains essential data on the physical properties of excipients, their safe use and potential toxicity.£415.00